Drug Hypersensitivity Clinical Trial
Official title:
Treatment of DRESS (Drug Reaction With Eosinophilia and Systemic Symptoms) With Tegeline®
Efficacy and tolerance of Tegeline® treatment in hypersensitivity syndrome. Immunological study of the T cell index phenotype and functionality in hypersensitivity syndrome.
n/a
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02839551 -
Optimal Doses for Drug Provocation Tests to Beta-lactams
|
N/A | |
Completed |
NCT00198419 -
Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)
|
Phase 1 | |
Completed |
NCT02839811 -
Medical Device for Drug Allergy Diagnosis
|
N/A | |
Completed |
NCT02983630 -
Allergy Testing of Patients Labeled as Penicillin Allergic
|
N/A | |
Completed |
NCT00198458 -
Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)
|
Phase 1 | |
Recruiting |
NCT04330118 -
Origin and Function of Eosinophilic Polynuclear During DRESS Syndrome
|
||
Completed |
NCT04421638 -
Cephalosporin Hypersensitivity
|
||
Recruiting |
NCT02031120 -
Management of Drug Hypersensitivity in Children
|
N/A | |
Completed |
NCT01276314 -
Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions
|
N/A | |
Completed |
NCT03158831 -
Drug Challenges Without Prior Skin Testing
|
Phase 1 | |
Completed |
NCT03076749 -
Predictive Models for Betalactam Allergy
|
N/A | |
Active, not recruiting |
NCT06428162 -
An Evaluation of Healthcare Providers' Adherence to Pharmacovigilance Practices in an African Community
|
||
Terminated |
NCT02844712 -
Negative Predictive Value of Drug Provocation Tests to Beta-lactams
|
N/A | |
Completed |
NCT03743220 -
Drug Provocation Test (DPT) to Non Steroidal Anti-inflammatory Drugs (NSAID)
|
||
Completed |
NCT03771118 -
Drug Provocation Test (DPT) to Paracetamol
|
||
Not yet recruiting |
NCT06406114 -
Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
|
Phase 2 | |
Completed |
NCT05269082 -
A Study to Assess the Hypersensitivity to TAK-880 Compared to Gammagard S/D in Blood of Children, Teenagers and Adults
|
||
Completed |
NCT04827602 -
Drug Allergy Labels After Drug Allergy Investigation
|